Analysing the effectiveness of Chlamydia screening

Chlamydia is a highly prevalent sexually transmitted infection which is normally asymptomatic. Chlamydia is a major public health concern since it is one of the biggest causes of infertility in the UK. A screening programme has been proposed and here we analyse its potential cost-effectiveness. Previous modelling analyses for Chlamydia screening have been inadequate at representing the dynamic complexity of the impact. Most notably, the impact on the population prevalence has been overlooked as well as the possibility for an individual to become re-infected after treatment. A system dynamics model was built using the array facility in the ithink software to represent a heterogeneous population. This population was disaggregated along two dimensions: age and sexual activity levels. Results suggest that the proposed screening programme would prevent significant numbers of infertility cases annually. Additionally, it could be paying for itself after about four years and recouping the initial outlay after about twelve years.

[1]  J. Hopwood,et al.  Chlamydia screening -- should it be offered as a routine? A feasibility study in family planning clinics. , 1990 .

[2]  Joy Melnikow,et al.  Cost-effectiveness Analysis Of Five Different Antibiotic Regimens For The Treatment Of Uncomplicated Chlamydia Trachomatis Cervicitis , 1995, The Journal of the American Board of Family Medicine.

[3]  J Schachter,et al.  Experience with the routine use of erythromycin for chlamydial infections in pregnancy. , 1986, The New England journal of medicine.

[4]  Julius Schachter,et al.  Experience with the routine use of erythromycin for chlamydial infections in pregnancy , 1987 .

[5]  J. Schwartz,et al.  Doxycycline Compared with Azithromycin for Treating Women with Genital Chlamydia trachomatis Infections: An Incremental Cost-Effectiveness Analysis , 1996, Annals of Internal Medicine.

[6]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[7]  A. Haddix,et al.  The Cost Effectiveness of Azithromycin for Chlamydia trachomatis Infections in Women , 1995, Sexually transmitted diseases.

[8]  C. Goldsmith,et al.  Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. , 1992, Archives of internal medicine.

[9]  R. Sweet,et al.  Prospective study of perinatal transmission of Chlamydia trachomatis. , 1986, JAMA.

[10]  Kaye Wellings,et al.  Sexual behaviour in Britain : national survey of sexual attitudes and lifestyles , 1994 .

[11]  J. Forrester.  Industrial Dynamics , 1997 .

[12]  A Széll,et al.  [Chlamydia trachomatis infections]. , 1998, Orvosi hetilap.

[13]  Darryl James Gove.  Simulation modelling of infectious diseases , 1997 .

[14]  James A. Yorke,et al.  Some equations modelling growth processes and gonorrhea epidemics , 1973 .

[15]  K. Wareham,et al.  Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy , 1993, The Lancet.

[16]  B. Backe,et al.  Cost Effectiveness of Testing for Chlamydial Infections in Asymptomatic Women , 1989, Medical care.

[17]  M. Millar,et al.  Detection of Chlamydia trachomatis in general practice urine samples. , 1994, The British journal of general practice : the journal of the Royal College of General Practitioners.

[18]  P. Yuen,et al.  Compendium of health statistics , 2000 .

[19]  P. Mårdh,et al.  An economic evaluation of screening for Chlamydia trachomatis in adolescent males. , 1993, JAMA.

[20]  J. Wadsworth,et al.  Estimating the sexual mixing patterns in the general population from those in people acquiring gonorrhoea infection: theoretical foundation and empirical findings. , 1995, Journal of epidemiology and community health.

[21]  A. Washington,et al.  A Cost-Based Decision Analysis for Chlamydia Screening in California Family Planning Clinics , 1988, Obstetrics and gynecology.

[22]  R. Rickard,et al.  Cost‐Benefit Analysis of Selective Screening Criteria for Chlamydia trachomatis Infection in Women Attending Colorado Family Planning Clinics , 1992, Sexually transmitted diseases.

[23]  P. Mårdh,et al.  A Cost-effectiveness Analysis of Screening and Treatment for Chlamydia trachomatis Infection in Asymptomatic Women , 1996, Annals of Internal Medicine.